Arcutis, Inc.’s ARQ-151 Development Program for Plaque Psoriasis
ARQ-151 Potential "Best in Class" Topical PDE4 inhibitor ARQ-151 Potentially Only Topical PDE4 inhibitor for Psoriasis Phase 2a Study in...
user
Utah Medical Products, Inc. Announces Quarterly Dividend
SALT LAKE CITY, UT / ACCESSWIRE / May 7, 2019 / Utah Medical Products, Inc. (NASDAQ: UTMD) announces that its...
International Cannabrands Announces Distribution Deal with Nabis
DENVER, CO / ACCESSWIRE / May 7, 2019 / International Cannabrands Inc. (CSE: JUJU) (the 'Company') is pleased to announce...
DECN’s Appeal Nearing Oral Arguments in its Patent Battle with Johnson & Johnson Over the Unjust Ruling in the Nevada Lower Court
Appeals Court Set to Hear and Then Decide DECN's Seminal Legal Question at Issue in Long Simmering Patent Battle with...
Adial Pharmaceuticals Announces Collaboration Agreement with Eurofins for Genetic Biomarker Testing to Support Upcoming Phase 3 Clinical Trial for Alcohol Use Disorder
CHARLOTTESVILLE, VA / ACCESSWIRE / May 7, 2019 / Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) www.adialpharma.com, a clinical-stage biopharmaceutical company...
Evotec SE to Report First Quarter 2019 Results on 14 May 2019
HAMBURG, GERMANY / ACCESSWIRE / May 7, 2019 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) will report...
VistaGen Therapeutics to Present at ChinaBio(R) Partnering Forum in Shanghai, China
SOUTH SAN FRANCISCO, CA / ACCESSWIRE / May 7, 2019 / VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing...
Aytu BioScience to Report Fiscal Third Quarter 2019 Results and Business Update
Live Conference Call and Webcast Scheduled for May 14, 2019, at 9:00 a.m. ET ENGLEWOOD, CO / ACCESSWIRE / May...
Preferred Dental Technologies Inc. (”Company”) (CSE: PDTI, US OTC: PDTTF): PDTI Receives 3D Patent Grant from US Patent and Trademark Office
WINNIPEG, MB / ACCESSWIRE / May 7, 2019 / Preferred Dental Technologies Inc. (PDTI) has been granted an additional patent...
CTD Announces New Expanded Access Program in Taiwan using Trappsol Cyclo for Niemann-Pick Disease type C
Program is open to two patients who completed CTD's clinical trial with Trappsol® Cyclo™ in the United States ALACHUA, FL...
Chinese Patent Office Issues Notice of Acceptance for Multiwavelength PhotoDynamic Therapy
TORONTO, ON / ACCESSWIRE / May 7, 2019 / Theralase® Technologies Inc. ("Theralase" or the "Company") (TSXV: TLT) (OTCQB: TLTFF),...
Apogenix to Present at Four Upcoming International Conferences
HEIDELBERG, GERMANY / ACCESSWIRE / May 7, 2019 / Apogenix, a biopharmaceutical company developing next generation immuno-oncology therapeutics, announced today...
Integrated BioPharma Names Christina Kay and Riva Sheppard as Co-Chief Executive Officers
HILLSIDE, NJ / ACCESSWIRE / May 6, 2019 / Integrated BioPharma, Inc. (OTCQB: INBP) (the "Company" or "INBP") announced today...
Heat Biologics Lead Director to Present at the ChinaBio 2019 Conference in Shanghai
DURHAM, NC / ACCESSWIRE / May 6, 2019 / Heat Biologics, Inc. (NASDAQ: HTBX), a biopharmaceutical company developing immunotherapies designed...
Theralase’s Phase Ib Non-Muscle Invasive Bladder Cancer Clinical Study Research Presented at the American Urological Association
TORONTO, ON / ACCESSWIRE / May 6, 2019 / Theralase® Technologies Inc. (''Theralase'' or the ''Company'') (TSXV: TLT) (OTCQB: TLTFF),...
1933 Industries CEO Appointed as Chairman of the Board, Issuance of Bonus Shares and Investor Relations Contract
VANCOUVER, BC / ACCESSWIRE / May 3, 2019 / 1933 Industries Inc. (the 'Company' or '1933 Industries') (CSE: TGIF) (OTCQX:...
New Research Shows Who’s Worried About Drug Tests At Work
By Matt Zajechowski You don’t have to be a pilot or pro athlete to fear drug testing for your employer....
Oncolytics Biotech(R) Announces Voting Results from the Annual General Meeting of Shareholders
CALGARY, AB and SAN DIEGO, CA / ACCESSWIRE / May 3, 2019 / Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC),...
Oncolytics Biotech (R) Reports 2019 First Quarter Financial Results and Operational Highlights
- Recent biomarker data identifies a simple blood test that may predict clinical response to pelareorep - - Interim data...
Invitation to MorphoSys Q1 2019 Conference Call on May 8, 2019
PLANEGG/MUNICH, GERMANY / ACCESSWIRE / May 2, 2019 / MorphoSys AG (FSE: MOR; Prime Standard Segment, MDAX & TecDAX; Nasdaq:...